Logo

Pillar Biosciences

In Brief This Week:, Hologic, Revvity, Pillar Biosciences, Mainz Biomed, More

News items for the week of Oct. 21, 2024.

Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe

AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.

FDA Approves Pillar Biosciences Pan-Cancer NGS Test for Solid Tumor Profiling

Previously approved for guiding EGFR- and KRAS-targeted therapy in specific tumor types, OncoReveal CDx can now be sold for general solid tumor profiling.

Beckman Coulter Life Sciences, Pillar Biosciences to Develop NGS Cancer Tests

Pillar will develop a series of tests for use on Beckman Coulter's Biomek NGeniuS Next Generation Library Preparation System. 

Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays

The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.